Community Health(CH:CG5)
CH:CG5
Community Health financials statements
Community Health (CG5) Ratios
0 Followers
Community Health Ratios
CH:CG5's free cash flow for Q3 2026 was $67.00M. For the 2026 fiscal year, CH:CG5's free cash flow was decreased by $-87.00M and operating cash flow was $154.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.46 | 1.41 | 1.50 | 1.41 | 1.47 |
| Quick Ratio | 1.32 | 1.27 | 1.34 | 1.25 | 1.32 |
| Cash Ratio | 0.12 | 0.02 | 0.02 | 0.05 | 0.21 |
| Solvency Ratio | 0.07 | -0.01 | 0.02 | 0.03 | 0.04 |
| Operating Cash Flow Ratio | 0.25 | 0.20 | 0.10 | 0.14 | -0.06 |
| Short-Term Operating Cash Flow Coverage | 4.31 | 3.56 | 1.45 | 1.78 | -0.74 |
| Net Current Asset Value | $ -10.81B | $ -12.07B | $ -12.07B | $ -12.32B | $ -12.55B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.88 | 0.86 | 0.84 | 0.84 | 0.84 |
| Debt-to-Equity Ratio | -8.31 | -6.32 | -8.75 | -9.06 | -9.35 |
| Debt-to-Capital Ratio | 1.14 | 1.19 | 1.13 | 1.12 | 1.12 |
| Long-Term Debt-to-Capital Ratio | 1.15 | 1.21 | 1.14 | 1.14 | 1.13 |
| Financial Leverage Ratio | -9.47 | -7.34 | -10.38 | -10.73 | -11.09 |
| Debt Service Coverage Ratio | 1.98 | 1.17 | 1.13 | 0.97 | 1.49 |
| Interest Coverage Ratio | 1.71 | 0.63 | 1.15 | 0.96 | 1.58 |
| Debt to Market Cap | 26.02 | 28.80 | 27.93 | 20.78 | 7.05 |
| Interest Debt Per Share | 93.23 | 98.14 | 99.75 | 102.83 | 108.14 |
| Net Debt to EBITDA | 5.60 | 9.66 | 9.37 | 10.51 | 7.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.92% | 41.71% | 40.69% | 40.18% | 41.11% |
| EBIT Margin | 12.78% | 6.67% | 6.97% | 5.89% | 10.33% |
| EBITDA Margin | 16.20% | 9.89% | 10.37% | 9.57% | 13.83% |
| Operating Profit Margin | 11.92% | 4.29% | 7.66% | 6.72% | 11.34% |
| Pretax Profit Margin | 5.80% | -2.24% | 1.66% | 2.86% | 4.03% |
| Net Profit Margin | 4.08% | -4.08% | -1.06% | 0.38% | 1.86% |
| Continuous Operations Profit Margin | 5.41% | -2.87% | 0.13% | 1.47% | 2.98% |
| Net Income Per EBT | 70.30% | 182.33% | -64.25% | 13.18% | 46.09% |
| EBT Per EBIT | 48.66% | -52.21% | 21.63% | 42.51% | 35.59% |
| Return on Assets (ROA) | 3.85% | -3.67% | -0.92% | 0.31% | 1.51% |
| Return on Equity (ROE) | -36.51% | 26.96% | 9.55% | -3.37% | -16.76% |
| Return on Capital Employed (ROCE) | 13.53% | 4.63% | 7.77% | 6.58% | 10.91% |
| Return on Invested Capital (ROIC) | 12.49% | 4.58% | 0.59% | 3.33% | 7.93% |
| Return on Tangible Assets | 5.22% | -5.11% | -1.29% | 0.45% | 2.14% |
| Earnings Yield | 122.14% | -130.64% | -32.59% | 8.27% | 13.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.53 | 5.16 | 5.29 | 5.71 | 5.68 |
| Payables Turnover | 13.06 | 9.39 | 9.13 | 10.65 | 10.05 |
| Inventory Turnover | 34.15 | 22.25 | 22.59 | 20.69 | 20.52 |
| Fixed Asset Turnover | 2.44 | 2.34 | 2.13 | 2.00 | 1.99 |
| Asset Turnover | 0.95 | 0.90 | 0.86 | 0.83 | 0.81 |
| Working Capital Turnover Ratio | 12.60 | 12.50 | 12.73 | 12.14 | 8.80 |
| Cash Conversion Cycle | 48.75 | 48.24 | 45.20 | 47.24 | 45.68 |
| Days of Sales Outstanding | 66.01 | 70.69 | 69.00 | 63.88 | 64.22 |
| Days of Inventory Outstanding | 10.69 | 16.41 | 16.16 | 17.64 | 17.79 |
| Days of Payables Outstanding | 27.95 | 38.86 | 39.96 | 34.28 | 36.33 |
| Operating Cycle | 76.70 | 87.10 | 85.16 | 81.52 | 82.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.07 | 3.63 | 1.61 | 2.33 | -1.03 |
| Free Cash Flow Per Share | 1.56 | 0.91 | -1.97 | -0.89 | -4.73 |
| Dividend Paid and CapEx Coverage Ratio | 1.62 | 1.33 | 0.45 | 0.72 | -0.28 |
| Capital Expenditure Coverage Ratio | 1.62 | 1.33 | 0.45 | 0.72 | -0.28 |
| Operating Cash Flow Coverage Ratio | 0.05 | 0.04 | 0.02 | 0.02 | -0.01 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.04 | 0.02 | 0.02 | -0.01 |
| Free Cash Flow Yield | 49.91% | 30.38% | -62.97% | -20.67% | -35.56% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 0.82 | -0.77 | -3.07 | 12.10 | 7.34 |
| Price-to-Sales (P/S) Ratio | 0.03 | 0.03 | 0.03 | 0.05 | 0.14 |
| Price-to-Book (P/B) Ratio | -0.30 | -0.21 | -0.29 | -0.41 | -1.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.00 | 3.29 | -1.59 | -4.84 | -2.81 |
| Price-to-Operating Cash Flow Ratio | 0.77 | 0.82 | 1.94 | 1.85 | -12.88 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -0.00 | 0.01 | -0.15 | -0.12 |
| Enterprise Value Multiple | 5.80 | 9.98 | 9.69 | 10.98 | 8.19 |
| Enterprise Value | 11.74B | 12.46B | 12.54B | 12.83B | 14.00B |
| EV to EBITDA | 5.80 | 9.98 | 9.69 | 10.98 | 8.19 |
| EV to Sales | 0.94 | 0.99 | 1.00 | 1.05 | 1.13 |
| EV to Free Cash Flow | 56.43 | 103.83 | -48.81 | -111.53 | -23.34 |
| EV to Operating Cash Flow | 21.61 | 25.96 | 59.73 | 42.75 | -106.89 |
| Tangible Book Value Per Share | -32.17 | -39.95 | -38.25 | -39.78 | -41.81 |
| Shareholders’ Equity Per Share | -10.44 | -14.49 | -10.68 | -10.61 | -10.82 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | -0.28 | 0.92 | 0.49 | 0.26 |
| Revenue Per Share | 93.48 | 95.64 | 95.79 | 94.80 | 97.57 |
| Net Income Per Share | 3.81 | -3.91 | -1.02 | 0.36 | 1.81 |
| Tax Burden | 0.70 | 1.82 | -0.64 | 0.13 | 0.46 |
| Interest Burden | 0.45 | -0.34 | 0.24 | 0.49 | 0.39 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.80 | -0.93 | -1.58 | 6.52 | -0.57 |
Currency in USD

